ArticleAdvances in experimental medicine and biology2025
Novel Potentially Pathogenic Variants in TBC1D32 Cause Non-syndromic Rod-Cone Degeneration.
Article in Advances in experimental medicine and biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Expanding the clinical and molecular spectrum of TBC1D32-related ciliopathy: case reports and literature Review.Journal of human genetics · 2025Review
- Multifaceted disruption of AMPA receptor signaling byComputational and structural biotechnology journal · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Inherited retinal degenerations (IRDs) are a group of Mendelian disorders characterized by progressive dysfunction and loss of rod and/or cone photoreceptors. The most common IRD is rod-cone degeneration (RCD, also known as retinitis pigmentosa), which starts with rod photoreceptor cell loss and eventually can lead to cone photoreceptor dysfunction and death. Thus, RCD initially manifests with loss of peripheral vision and night blindness and can lead to central vision loss as well. RCD is genetically heterogeneous with mutations in over 90 genes that have been so far associated with this disease. Recently, TBC1D32 has been proposed as a novel recessive RCD gene, as rare bi-allelic pathogenic variants were found in three unrelated European families. In this report, we describe a fourth RCD family of European descent carrying two novel mutations in TBC1D32, thus providing secondary evidence for this recent association.
Indexed as
Identifiers
39930170What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.